Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
4/23/2024
NMPA Issues Announcement on Further Strengthening the Drug Distributio...
4/23/2024
NMPA Issues the Announcement on Relevant Matters Concerning the Optimi...
4/18/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (81...
4/18/2024
CDE Issues the Detailed Rules on Adding Pediatric Information to the P...
4/17/2024
NMPA Withdraws Approvals for 87 Drug Products
4/16/2024
NMPA Issues the List of Reference Formulations for GQCE Studies (79th ...
4/15/2024
NHC Issues the Guidelines for the Diagnosis and Treatment of Primary L...
4/11/2024
CDE Issues the Summary of Bioequivalence Studies for Generic Drugs
4/8/2024
NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules
4/3/2024
NMPA Issues the Principles and Procedures for Exploratory Studies of D...
4/3/2024
NMPA Issues Announcement on the Implementation of Electronic Drug Regi...
4/2/2024
CDE Solicits Comments on the Pharmaceutical Self-Assessment Report for...
4/2/2024
NHC Holds the 2024 National Drug Administration Work Conference
4/1/2024
CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...
4/1/2024
NMPA Announces Package Insert Revision of Metronidazole Injection and ...
3/30/2024
NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...
3/27/2024
NMPA Holds National Conference on Drug Registration and Post-Market Re...
3/27/2024
NIFDC Issues the 2023 National Drug Sample Inspection Annual Report
3/26/2024
NMPA Publishes the 2023 Annual Report for Adverse Drug Reaction Monito...
3/22/2024
NMPA Announces Package Insert Revision of Multiple Drugs
3/22/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
3/22/2024
China Eases Cross-Border Data Transfer Rules to Alleviate Concerns of ...
3/19/2024
NDRC Issues 2024 Edition of the Guiding Catalog for Adjustment of Indu...
3/18/2024
CDE Publicizes the List of Reference Formulations for GQCE Studies (80...
3/12/2024
CDE Issues the List of Reference Formulations for GQCE Studies (78th B...
3/6/2024
US Senate Committee Approves Bill That Could Restrict Chinese Biotech
3/6/2024
CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
3/5/2024
NMPA Announces Package Insert Revision of Synovitis Formulations
2/29/2024
CDE Issues the Technical Guidelines for Clinical Trial of Growth Hormo...
2/23/2024
NMPA Issues the Rules for the Application of Discretion in Administra...
Page:
1
/
9
Total number of articles:
258
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit